Delivery Order SPE2DB22D2211-SPE2DB25FSCCF
- Not listed
- The Defense Logistics Agency awarded a $11,966.22 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $7,367.70 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes on September 16, 2025, with a completion date of September 17, 2025. This delivery order is issued under a firm fixed-price contract without set-aside provisions and represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 ml syringes with a firm fixed price ceiling value of $10,116.77. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,709.46 for Dupixent 300 mg/2 mL syringes on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes with a ceiling value of $14,471.46 under a firm fixed-price contract type. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive set-aside delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $15,257.22 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill this order from its corporate office location. This delivery order falls...
- The Defense Logistics Agency awarded a $47,704.56 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $44,935.54 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-line procurement under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $23,362.12 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on a firm fixed price basis. The contract was competitively awarded without set-aside restrictions and carries an ultimate completion date of September 12, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $18,005.78 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCCFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 ml syringes with a ceiling value of $1,907.46 under a firm fixed price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Dupixent delivery fulfills part of the company's obligation to provide specialty medications and related medical commodities to the Defense Health Agency and other federal healthcare customers through this expansive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/4/25 |